About ZELLKRAFTWERK
ZELLKRAFTWERK is a company based in Leipzig (Germany) founded in 2012 by Jan Detmers and Christian Hennig was acquired by Canopy Biosciences in April 2019. ZELLKRAFTWERK offers products and services including CellScape, NanoString, and GeoMx. ZELLKRAFTWERK operates in a competitive market with competitors including Cytek Biosciences, Accuri Cytometers, ACEA Biosciences, Bioaffinity technologies and Orflo, among others.
- Headquarter Leipzig, Germany
- Founders Jan Detmers, Christian Hennig
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Zellkraftwerk Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Canopy Biosciences
(Apr 29, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ZELLKRAFTWERK
ZELLKRAFTWERK offers a comprehensive portfolio of products and services, including CellScape, NanoString, and GeoMx.
Instrument for biomarker imaging and spatial quantification.
Platform for analyzing up to 800 genes in samples.
Service for RNA sequencing and spatial genomics.
Funding Insights of ZELLKRAFTWERK
Detailed funding history for ZELLKRAFTWERK
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in ZELLKRAFTWERK
ZELLKRAFTWERK has secured backing from 1 investor. Prominent investors backing the company include Canopy Biosciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Cell line engineering services are offered via CRISPR-Cas9 technology.
|
Locked | Locked | Locked |
Investor details for ZELLKRAFTWERK
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ZELLKRAFTWERK
Investment portfolio details for ZELLKRAFTWERK
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ZELLKRAFTWERK
Detailed financials for ZELLKRAFTWERK
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Zellkraftwerk Comparisons
Peer comparison for ZELLKRAFTWERK
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ZELLKRAFTWERK
ZELLKRAFTWERK operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cytek Biosciences, Accuri Cytometers, ACEA Biosciences, Bioaffinity technologies and Orflo, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Advanced flow cytometry systems are manufactured for research applications.
|
|
| Locked | Locked | Locked |
Compact flow cytometers for cell analysis are developed and provided.
|
|
| Locked | Locked | Locked |
Instruments for life science research are developed and marketed.
|
|
| Locked | Locked | Locked |
IVD platforms are developed to detect and target cancer cells.
|
|
| Locked | Locked | Locked |
Instrumentation for cell and protein analysis is developed and marketed.
|
|
| Locked | Locked | Locked |
Offers advanced tools for nanoparticle analysis in biotechnology and healthcare.
|
Detailed competitors of ZELLKRAFTWERK
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Zellkraftwerk
Complete news archive for ZELLKRAFTWERK
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ZELLKRAFTWERK
ZELLKRAFTWERK was founded in 2012.
ZELLKRAFTWERK is headquartered in Leipzig, Germany. It is registered at Leipzig, Saxony, Germany.
Developer chip cytometry technology. It provides automated analysis of fluorescent biomarkers on living cells and long-term stored bio-banked cells. It uses sample sources such as blood or fresh frozen tissues. It has applications in biobanking, tissue cytometry, virtual sorting, and others.
ZELLKRAFTWERK's top competitors include Cytek Biosciences, Bioaffinity technologies and Accuri Cytometers.
ZELLKRAFTWERK offers CellScape, NanoString, and GeoMx.
ZELLKRAFTWERK has 1 investor. Key investors include Canopy Biosciences.